Dipyridamole (Lannett Company, Inc.)
Welcome to the PulseAid listing for the Dipyridamole drug offered from Lannett Company, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lannett Company, Inc. |
NON-PROPRIETARY NAME: | Dipyridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-04-23 |
END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipyridamole from Lannett Company, Inc. |
LABELER NAME: | Lannett Company, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2008-04-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0527-1461_2210856e-0bac-4af3-89cd-238b46efe6e2 |
PRODUCT NDC: | 0527-1461 |
APPLICATION NUMBER: | ANDA040898 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: